Latest News

COVID Virus Can Remain in the Body Over a Year


 

Scientists at the University of California, San Francisco, have discovered that remnants of the COVID-19 virus can linger in blood and tissue for more than a year after a person is first infected.

In their research on long COVID, the scientists found COVID antigens in the blood for up to 14 months after infection, and in tissue samples for more than 2 years after infection.

“These two studies provide some of the strongest evidence so far that COVID antigens can persist in some people, even though we think they have normal immune responses,” Michael Peluso, MD, an infectious disease researcher in the UCSF School of Medicine, who led both studies, said in a statement.

Scientists don’t know what causes long COVID, in which symptoms of the illness persist months or years after recovery. The most common symptoms are extreme fatigue, shortness of breath, loss of smell, and muscle aches.

The UCSF research team examined blood samples from 171 infected people and found the COVID “spike” protein was still present up to 14 months after infection in some people. The antigens were found more often in people who were hospitalized with COVID or who reported being very sick but were not hospitalized.

Researchers next looked at the UCSF Long COVID Tissue Bank, which contains samples donated by patients with and without long COVID.

They found portions of viral RNA in the tissue up to 2 years after people were infected, though there was no evidence of reinfection. Those viral fragments were found in connective tissue where immune cells are, suggesting that the fragments caused the immune system to attack, according to the researchers.

The UCSF team is running clinical trials to find out if monoclonal antibodies or antiviral drugs can remove the virus.

The findings were presented in Denver this week at the Conference on Retroviruses and Opportunistic Infections.

A version of this article appeared on WebMD.com.

Recommended Reading

Long COVID and mental illness: New guidance
Journal of Clinical Outcomes Management
Chest pain with long COVID common but undertreated
Journal of Clinical Outcomes Management
New tests may finally diagnose long COVID
Journal of Clinical Outcomes Management
Some reasons to get off the fence about COVID booster
Journal of Clinical Outcomes Management
Long COVID: New Info on Who Is Most Likely to Get It
Journal of Clinical Outcomes Management
Long COVID Has Caused Thousands of US Deaths: New CDC Data
Journal of Clinical Outcomes Management
New Evidence Suggests Long COVID Could Be a Brain Injury
Journal of Clinical Outcomes Management
Long COVID: Another Great Pretender
Journal of Clinical Outcomes Management
Study IDs Immune Abnormality Possibly Causing Long COVID
Journal of Clinical Outcomes Management
Biological Sex Differences: Key to Understanding Long COVID?
Journal of Clinical Outcomes Management